Applications including "JP Draft"

LC148 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(3), Related Substances 3) -

LC InertSearch Inertsil ODS-4
LC147 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(2), Related Substances 2) -

LC InertSearch InertSustain AQ-C18
LC146 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(1), Related Substances 1) -

LC InertSearch InertSustain C18
LC145 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia , Solifenacin Succinate, ASSAY) -

LC InertSearch InertSustain AQ-C18
LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC InertSearch InertSustain C18
LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC InertSearch InertSustain AQ-C18
LB983 - Analysis of Lornoxicam -

LC InertSearch Inertsil ODS-4
LB977 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain AQ-C18
LB973 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB907 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB906 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB905 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB904 - Analysis of Celecoxib -

LC InertSearch Inertsil Ph-3
LB903 - Analysis of Perospirone hydrochloride -

LC InertSearch InertSustain C18

Applications including "JP Draft"

LC148 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(3), Related Substances 3) -

LC147 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(2), Related Substances 2) -

LC146 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia, Solifenacin Succinate, Purity(1), Related Substances 1) -

LC145 - Analysis of Solifenacin succinate (Under the Condition of draft for the Japanese Pharmacopoeia , Solifenacin Succinate, ASSAY) -

LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LB983 - Analysis of Lornoxicam -

LB977 - Analysis of Dapagliflozin propandiol -

LB973 - Analysis of Dapagliflozin propandiol -

LB907 - Analysis of Aripiprazole -

LB906 - Analysis of Aripiprazole -

LB905 - Analysis of Aripiprazole -

LB904 - Analysis of Celecoxib -

LB903 - Analysis of Perospirone hydrochloride -

Application Search